Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Prophase Labs ( (PRPH) ) has provided an update.
On November 30, 2025, Prophase Labs‘ stockholders approved a reverse stock split of its common stock at a ratio of one share for every ten shares, effective December 2, 2025. This move was aimed at increasing the per-share trading price to meet NASDAQ’s continued listing requirements. The reverse stock split did not alter stockholders’ percentage ownership, except for cash adjustments for fractional shares, and the company’s common stock continues to trade under the symbol ‘PRPH’.
The most recent analyst rating on (PRPH) stock is a Hold with a $0.13 price target. To see the full list of analyst forecasts on Prophase Labs stock, see the PRPH Stock Forecast page.
Spark’s Take on PRPH Stock
According to Spark, TipRanks’ AI Analyst, PRPH is a Neutral.
Prophase Labs’ overall stock score is primarily impacted by its weak financial performance, characterized by declining revenues and negative profitability metrics. The bearish technical indicators and concerning valuation metrics further weigh on the score. While there are some positive developments from the earnings call and corporate events, they are not sufficient to offset the significant financial and operational challenges the company faces.
To see Spark’s full report on PRPH stock, click here.
More about Prophase Labs
Average Trading Volume: 2,256,706
Technical Sentiment Signal: Strong Sell
Current Market Cap: $6.7M
See more insights into PRPH stock on TipRanks’ Stock Analysis page.